189 related articles for article (PubMed ID: 23089761)
1. Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.
Jensen RH; Johansen HK; Arendrup MC
Antimicrob Agents Chemother; 2013 Jan; 57(1):614-7. PubMed ID: 23089761
[TBL] [Abstract][Full Text] [Related]
2. Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy.
Khan Z; Ahmad S; Mokaddas E; Meis JF; Joseph L; Abdullah A; Vayalil S
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437623
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
[TBL] [Abstract][Full Text] [Related]
4. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
5. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Cleary JD; Garcia-Effron G; Chapman SW; Perlin DS
Antimicrob Agents Chemother; 2008 Jun; 52(6):2263-5. PubMed ID: 18378714
[TBL] [Abstract][Full Text] [Related]
6. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
[TBL] [Abstract][Full Text] [Related]
7. Novel FKS mutations associated with echinocandin resistance in Candida species.
Garcia-Effron G; Chua DJ; Tomada JR; DiPersio J; Perlin DS; Ghannoum M; Bonilla H
Antimicrob Agents Chemother; 2010 May; 54(5):2225-7. PubMed ID: 20145084
[TBL] [Abstract][Full Text] [Related]
8. Echinocandin failure case due to a previously unreported FKS1 mutation in Candida krusei.
Jensen RH; Justesen US; Rewes A; Perlin DS; Arendrup MC
Antimicrob Agents Chemother; 2014 Jun; 58(6):3550-2. PubMed ID: 24687511
[TBL] [Abstract][Full Text] [Related]
9. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
Alexander BD; Johnson MD; Pfeiffer CD; Jiménez-Ortigosa C; Catania J; Booker R; Castanheira M; Messer SA; Perlin DS; Pfaller MA
Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
[TBL] [Abstract][Full Text] [Related]
10. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
11. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden.
Axner-Elings M; Botero-Kleiven S; Jensen RH; Arendrup MC
J Clin Microbiol; 2011 Jul; 49(7):2516-21. PubMed ID: 21543574
[TBL] [Abstract][Full Text] [Related]
12. Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.
Dudiuk C; Macedo D; Leonardelli F; Theill L; Cabeza MS; Gamarra S; Garcia-Effron G
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242659
[No Abstract] [Full Text] [Related]
13. A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.
Rocha EM; Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2007 Nov; 51(11):4174-6. PubMed ID: 17724146
[TBL] [Abstract][Full Text] [Related]
14. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Garcia-Effron G; Kontoyiannis DP; Lewis RE; Perlin DS
Antimicrob Agents Chemother; 2008 Nov; 52(11):4181-3. PubMed ID: 18794386
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Candida tropicalis resistant to caspofungin.
Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
[No Abstract] [Full Text] [Related]
16. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
17.
You L; Qian W; Yang Q; Mao L; Zhu L; Huang X; Jin J; Meng H
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28507109
[TBL] [Abstract][Full Text] [Related]
18. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
Healey KR; Nagasaki Y; Zimmerman M; Kordalewska M; Park S; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
[No Abstract] [Full Text] [Related]
19. First Case of Echinocandin-Resistant Candida albicans in Korea.
Park MS; Park JE; Song DJ; Huh HJ; Park S; Kang CI; Shin JH; Lee NY
Ann Lab Med; 2017 Nov; 37(6):556-558. PubMed ID: 28841000
[No Abstract] [Full Text] [Related]
20. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
